Kinnate Biopharma (KNTE)
NASDAQ:KNTE

Kinnate Biopharma (KNTE) Stock Investors

221 Followers
Based on 688,865 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold KNTE
On average, investors allocate 3.50% of their portfolios to KNTE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding KNTE

0.4%
Last 7
Days
5.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding KNTE, out of 688,865 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

KNTE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$4.30
Opened
0.36%
$3.14
Opened
0.45%
$4.04
Opened
0.00%
$4.30
Based on the activity of 12,730 investors who made their portfolios public
The table shows changes in KNTE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

KNTE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.07%
-0.05%
+0.36%
37.85B
Healthcare
Coherus Biosciences
2.48%
-1.23%
+814.97%
438.59M
Healthcare
Micron
5.66%
-0.63%
-2.38%
74.71B
Technology
Li Auto
5.58%
-0.25%
+2.94%
28.68B
Consumer Cyclical
ChargePoint Holdings
4.57%
+0.97%
+1.40%
1.81B
Technology
Roku
5.12%
-0.59%
-2.44%
8.39B
Technology
Marvell
4.81%
-0.14%
+1.47%
45.34B
Technology
Plug Power
4.80%
-0.39%
-0.23%
4.65B
Energy
Merck & Company
4.66%
-0.20%
-2.64%
263.75B
Healthcare
Nikola
6.44%
-0.42%
-1.06%
1.34B
Energy
Based on the activity of 688,865 active portfolios
Open your Smart Portfolio

KNTE Investor Analysis

KNTE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.7%
of KNTE holders
are under 35
Average Segment Performance
Average P/E Ratio-29.29
Beta9.51
Dividend Yield5.66%
KNTE investors between 35–55

Between 35–55

12.7%
Last 30 days
Holdings Change
41.1%
of KNTE holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.99
Beta14.43
Dividend Yield18.73%
KNTE investors over 55

Over 55

2.1%
Last 30 days
Holdings Change
48.2%
of KNTE holders
are over 55
Average Segment Performance
Average P/E Ratio-18.64
Beta5.43
Dividend Yield5.39%
Overview of age group and performance of KNTE stock investors
See who invests in KNTE according to age group and performance.

FAQ

How many retail Investors hold KNTE?
<0.1% of TipRank’s retail investors hold KNTE in their portfolios.
    What is KNTE Investor Sentiment?
    KNTE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of KNTE in the last 7 days?
      ▼ 0.4% of TipRank’s retail investors changed their holding of KNTE in the last 7 days.
        What percentage of retail investors changed their holding of KNTE in the last 30 days?
        ▼ 5.0% of TipRank’s retail investors changed their holding of KNTE in the last 30 days.
          What is the average age of retail investors who hold KNTE?
          The average age of KNTE Holders is over 55.
            What other stocks have KNTE investors also bought?
            KNTE Investors also bought MRNA, CHRS, MU, LI, CHPT, ROKU, MRVL, PLUG, MRK, NKLA.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              CORCencora
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis